Prescribing benzodiazepines - A critical incident study of a physician dilemma

Social Science and Medicine

Volumn 49, Issue 4, 1999, Pages 459-467

  Bendtsen, Preben ^a   Hensing, Gunnel ^a   McKenzie, Lotta ^a   Stridsman, Anna Karin ^a  

^a Fac H   (Sweden)

Author keywords

Benzodiazepines; Dilemma; Physician; Prescription; Primary health care; Sweden

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ANXIETY NEUROSIS; ARTICLE; CONFLICT; DATA ANALYSIS; GENERAL PRACTITIONER; INSOMNIA; MEDICAL DECISION MAKING; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOMOTOR PERFORMANCE; SWEDEN; TRANQUILIZING ACTIVITY;

BENZODIAZEPINES; FAMILY PRACTICE; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 0032975084     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(99)00133-1     Document Type: Article

References (34)

1. Barter G., Cormack M. The long-term use of benzodiazepines: patients' views accounts and experiences. Family Practice. 13:1996;491-497.
2. Björndal A., Fugelli P. Can regional differences in consumption of tranquillisers and hypnotics be explained by variations of general practitioners' threshold of prescribing? A methodological study. Scandinavian Journal of Primary Care. 7:1989;67-71.
3. Boixet M., Batlle E., Bolibar I. Benzodiazepines in primary health care: a survey of general practitioners prescribing patterns. Addiction. 91:1996;549-556.
4. Bradley C.P. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. British Journal of General Practitioners. 42:1992;454-458.
5. Bradley C.P. Turning anecdotes into data: the critical incident technique. Family Practice. 9:1992;98-103.
6. Bradley C.P. Uncomfortable prescribing decisions: a critical incident study. British Medical Journal. 304:1992;294-296.
7. Britten N., Brant S., Cairns A., Hall W.W., Jones I., Salisbury C., Virji A., Herxheimer A. Continued prescribing of inappropriate drugs in general practice. Journal of Clinical Pharmacy and Therapeutics. 20:1995;199-205.
8. Cormack M., Howells E. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Family Practice. 9:1992;466-471.
9. Flanagan J.C. The critical incident technique. Psychological Bulletin. 51:1954;327-358.
10. Heiman E.M., Wood G. Patient characteristics of clinical attitudes influencing the prescribing of benzodiazepines. Journal of clinical psychiatry. 42:1981;71-73.
11. Hensing G., Timpka T., Alexanderson K. Dilemmas in the daily work of social insurance officers. Scandinavian Journal of Social Wellfare. 6:1997;301-309.
12. Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time: a 13-year follow-up in a Swedish community. Social Science & Medicine. 44:1997;1871-1880.
13. Isacson D., Carsjö K., Bergman U., Blackburn J.L. Long-term use of benzodiazepines in a Swedish community; an eight-year follow-up. Journal of clinical Epidemiology. 45:1992;429-436.
14. Lipsky M. Street-level bureaucracy. Dilemmas of the individual in public services. 1980;Russel Sage Foundation, New York.
15. Livingston M.G. Benzodiazepine dependence. British Journal of Hospital Medicine. 51:1994;281-286.
16. Mattila M., Seppälä T., Mattila K.J. Combined effects of buspirone and diazepam on objective and subjective tests of performance in healthy volunteers. Clinical Pharmacological Therapy. 40:1986;620-626.
17. Mattila M.J., Mattila M., Aranko K. Objective and subjective assessments of the effects of flupentioxol and benzodiazepines on human psychomotor performance. Psychopharmacology. 95:1988;323-328.
18. Morales-Suarez-Varela M., Jaen-Martinez F., Llopis-Gonzaöez A., Silla Sobrecases B. Sociodemographic characteristics of female habitual benzodiazepine consumers in the catchment area of a health care centre. Scandinavian Journal of Social Medicine. 25:1997;176-179.
19. Norman I.J., Redfern S.J., Tomalin D.A., Oliver S. Developing Flanagan's critical incident technique to elicit indicators of high and low quality nursing care from patients and their nurses. Journal of Advanced Nursing. 17:1992;590-600.
20. Patton M.Q. Qualitative evaluation methods. 1980;Sage Publications Inc, London.
21. Paykel E.S., Priest R.G. Recognition and management of depression in general practice: consensus statement. British Medical Journal. 305:1992;1198-1202.
22. Perez G.G., Tudor R. A post-marketing surveillance survey on the use of dipotassium clorazepate in clinical practice in the Philipines. Current Medical Research and Opinion. 13:1993;175-186.
23. Peturson H. The benzodiazepine withdrawal syndrome. Addiction. 89:1994;1455-1459.
24. Ranstam J., Merlo J., Blennow G., Hanson B.S., Östergren P.O., Melander A. Impaired cognitive function in elderly men exposed to benzodiazepines or other anxiolytics. European Journal of Public Health. 7:1997;149-152.
25. Rutz, W., 1992 Evaluation of an educational program on depressive disorders given to general practitioners on Gotland: short and long-term effects. Ph.D. thesis, Faculty of Health, department of Psychiatry, University of Linköping, Sweden.
26. Schwartz H.I., Blank K. Regulation of benzodiazepine prescribing practices: Clinical Implications. General Hospital Psychiatry. 13:1991;219-224.
27. Silverman D. Interpreting qualitative data. 1993;SAGE Publications, London.
28. Simon G.E., VonKorff M., Bsarlow W., Pabiniak C., Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organisation sample. Journal of Clinical Epidemiologi. 49:1996;1067-1073.
29. Beroendeframkallande psykofarmaka. Att behandla och förebygga beroende och missbruk. Addictive psychopharmacological drugs. How to treat and prevent dependence and abuse :1990;Allmänna Råd, Socialstyrelsen (National Medical Board), Stockholm.
30. Säljö R. The Written World. 1988;Springer-Verlag, Berlin.
31. Timpka T., Hensing G., Alexanderson K. Dilemmas in sickness certification among Swedish physicians. European Journal of Public Health. 5:1995;215-219.
32. Uhlenhuth E.H., Balter M.B., Ban T.A., Yang K. International study expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications. II. Pharmacotherapy of anxiety disorders. Journal of Affectice Disorders. 35:1995;153-162.
33. WHO, 1996. Investing in health research and development. Report of the ad hoc committee on health research relating to the future intervention options. Geneva.
34. Woods J.H., Winder G. Current benzodiazepine issues. Psychopharmacology. 118:1995;107-115.